Lars Riedemann
Impact in
- Health Informatics top 10%
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in
- Genetics 4
- Glioma Diagnosis and Treatment 4
-
- Brain Metastases and Treatment 3
- Co-authors
- Rakesh K. Jain (2 shared papers)Frank Winkler (4 shared papers)Thomas Schmidt (2 shared papers)Georg Halder (1 shared paper)Iván M. Moya (1 shared paper)Carmen Ruiz de Almodóvar (1 shared paper)Aı̈da Valls (1 shared paper)Ying Shen (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)npj Digital Medicine (1 paper)The Lancet Digital Health (1 paper)The Pharmacogenomics Journal (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Lars Riedemann
10 papers receiving 716 citations
Peers
Comparison fields: 5 of 94
- Health Informatics 17
- Cell Biology 199
- Genetics 120
- Sensory Systems 48
- Neurology 51
Countries citing papers authored by Lars Riedemann
This map shows the geographic impact of Lars Riedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Riedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Riedemann more than expected).
Fields of papers citing papers by Lars Riedemann
This network shows the impact of papers produced by Lars Riedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Riedemann. The network helps show where Lars Riedemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Riedemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 273 | |
| 2 | 2013 | 177 | |
| 3 | 2007 | 86 | |
| 4 | 2022 | 83 | |
| 5 | 2012 | 40 | |
| 6 | 2020 | 21 | |
| 7 | 2021 | 15 | |
| 8 | 2015 | 14 | |
| 9 | 2024 | 13 | |
| 10 | 2018 | 1 |
About Lars Riedemann
Lars Riedemann is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 10 papers that have together received 723 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (3 papers), Protein Degradation and Inhibitors (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Electron Spin Resonance Studies (1 paper). The work is most often cited by research in Health Informatics (17 citations), Cell Biology (199 citations), Genetics (120 citations), Sensory Systems (48 citations) and Neurology (51 citations). Lars Riedemann has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Rakesh K. Jain, Frank Winkler, Thomas Schmidt, Georg Halder, Iván M. Moya, Carmen Ruiz de Almodóvar, Aı̈da Valls, Ying Shen, Géza Schermann and Gergely Solecki. Their work appears in journals such as Molecular Cancer Therapeutics, International Journal of Radiation Oncology*Biology*Physics, npj Digital Medicine, The Lancet Digital Health and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.